4DMedical Limited / Fundamentals
Income statement
- Net revenue
€3.83M - Cost of goods sold
€14.99M - Gross profit
-€11.15M - SG&A expenses
€27.25M - R&D expenses
€2.42M - EBITDA
-€43.32M - D&A
€2.27M - EBIT
-€40.82M - Interest expenses
€187.12K - EBT
-€42.23M - Tax expenses
-€3.05M - Net income
-€39.17M
Cash flow statement
- Net deferred tax
-€907.83K - Non-cash items
-€8.78M - Changes in working capital
-€408.52K - Operating cash flow
-€34.87M - Capex
€717.98K - Other investing cash flow
-€373.64K - Net investing cash flow
-€23.07M - Total cash dividends paid
€0.00 - Issuance of common stock
€42.03M - Debt repayment
-€256.05K - Other financing cash flow
€14.26M - Net financing cash flow
€41.36M - Foreign exchange effects
-€41.40K - Net change in cash
€453.02K - Cash at end of period
€8.88M - Free cash flow
-€34.15M
Balance sheet
- Cash and cash equivalents
€8.88M - Cash and short-term investments
€8.88M - Total receivables
€597.84K - Inventory
€571.81K - Other current assets
€2.58M - Total current assets
€12.63M - Property, plant & equipment
€4.41M - Goodwill
€23.78M - Intangible assets
€13.75M - Long-term investments
€0.00 - Other non-current assets
€2.21M - Total non-current assets
€44.15M - Total assets
€56.78M - Accounts payable
€3.06M - Short-term debt
€576.79K - Other current liabilities
€8.65M - Total current liabilities
€12.28M - Long-term debt
€2.11M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€9.07M - Total non-current liabilities
€11.18M - Total liabilities
€23.46M - Common stock
€122.36M - Retained earnings
-€90.91M - Other equity
€1.87M - Total equity
€33.32M - Total liabilities and shareholders' equity
€56.78M
Company information
- Market capitalization
€62.58M - Employees
145 - Enterprise Value
€123.87M
Company ratios
- Gross margin
-
-291.2% Much worse than peer group: -13.1% - EBITDA margin
-
-1,130.9% Much better than peer group: -261,369.7% - EBIT margin
-
-1,065.5% Much better than peer group: -171,348.2% - EBT margin
-
-1,102.3% Much better than peer group: -163,168.4% - Net margin
-
-1,022.6% Much better than peer group: -123,463.4% - ROE
-
-117.6% Much worse than peer group: 17.1% - ROA
-
-69.0% Worse than peer group: -58.4% - Asset turnover
-
6.7% Much worse than peer group: 60.1% - FCF margin
-
-929.0% Much better than peer group: -5,585.7% - FCF yield
-56.9% - Efficiency ratio
1,230.9% - Net sales per employee
-
€26.42K - Net income per employee
-
-€270.16K